# rTMS to Improve Cognition in Parkinson's

> **NCT03836950** · PHASE1,PHASE2 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 56 (estimated)

## Conditions studied

- Parkinson's Disease
- Mild Cognitive Impairment

## Interventions

- **DEVICE:** MagVenture MagProX100 stimulator (MagVenture, Falun, Denmark)
- **DEVICE:** MagVenture MagProX100 stimulator (MagVenture, Falun, Denmark)

## Key facts

- **NCT ID:** NCT03836950
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-04-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2028-03-30
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03836950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03836950, "rTMS to Improve Cognition in Parkinson's". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03836950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*